Innovation funding

On July 9, 2025, the NHS Cancer Programme granted £14.4 million to seven projects through the third Innovation Open Call. The projects aimed to fast-track the implementation of proven, late-stage innovations for the early detection and diagnosis of cancer.

On June 20, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (seven topics) and clinical guidelines (three topics).

On July 1, 2025, the revised EBM (German Uniform Evaluation Standard) catalog for the third quarter of 2025 came into force. The main changes introduced concern updates of the contents (services legends, preambles of several EBM subchapters) and the introduction of new EBM codes for the reimbursement of transmitters for telemonitoring and telemedical monitoring of implantable cardiac devices, as well as codes for the services provided within the co-funded study on low-dose pulsed ultrasound for pseudarthrosis.

On May 26, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) announced that 49 applications for innovation funding of healthcare research projects were accepted.

In late May 2025, the Innovation Committee of the Federal Joint Committee (G-BA) published decisions recommending the transfer of several completed healthcare research and new forms of care projects into standard care. These projects addressed a range of topics, including a web-based self-help program for relatives of individuals with depressive disorders, strengthening crisis resilience in outpatient medical practices, and structured aftercare following bariatric surgery.

In May 2025, the Ministry of Health, Welfare, and Sport provided further details on terminating "Subsidy Scheme for Promising Care". The program will be discontinued as of January 1, 2026, without any follow-up measures or financing. No new rounds for submission of proposals will be available. Nothing will change for the 28 ongoing projects and projects expected to be awarded later in 2025 as a result of the last completed rounds.

On April 22, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) announced the receipt of 156 applications (project ideas) for innovation funding of projects for new forms of care. The majority of applications (n=117) were submitted in response to topic-specific funding calls, including integration of AI systems into healthcare structures and processes, strengthening child and youth health, and women's health. A decision on which project ideas will be invited to submit full proposals is expected in the fourth quarter of 2025.

On April 11, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) announced the opening of the application period for the submission of topics for upcoming funding opportunities in the areas of healthcare research and new forms of care. The deadline for submitting topic proposals is June 20, 2025.

On March 26, 2025, the Law to accelerate the digitalization of the healthcare system (Digital Law, DigiG) came into force.

On March 19, 2025, the NHS Innovation Accelerator (NIA) announced 28 new innovators (“Fellows”) with healthcare solutions awarded to join the program in 2025. NIA provides intensive, tailored support to proven healthcare solutions, helping to accelerate their adoption and maximize their impact across the NHS. Awarded innovations concern e-Health, in-vitro diagnostic, gynecology, neuromodulation, and sustainability.

In late February 2025, the Innovation Committee at the Federal Joint Committee (G-BA) published the decision recommending the transfer to standard care for the completed project in the peripheral vascular field. The project was dedicated to the integration and spatial analysis of regional, site-specific, and patient-specific factors to improve the quality of care in carotid artery revascularization.

On January 30, 2025, the Institute for the Hospital Remuneration System (InEK) published the list of requests for innovation funding (NUB) submitted by hospitals in 2024. The medical technologies of cardiovascular, endoscopy, extracorporeal, gastrointestinal, neuromodulation, peripheral vascular, and other technology groups obtained positive status 1.